T细胞中的线粒体功能障碍:专注于炎症性肠病
Hoyul Lee1, Jae-Han Jeon1,2, Eun Soo Kim3
1Research Institute of Aging and Metabolism, Kyungpook National University, Daegu, Republic of Korea.
Frontiers in immunology
|October 9, 2023
概括
线粒体功能障碍和胆固醇T细胞中的代谢重编程驱动炎症性肠病 (IBD). 针对这些途径为IBD治疗提供了潜在的治疗策略.
科学领域:
- 免疫学 免疫学 免疫学
- 代谢过程中的代谢.
- 线粒体生物学 线粒体生物学
背景情况:
- 线粒体是免疫反应和炎症中的代谢重编程的核心.
- 胆固醇T细胞和炎症性肠病 (IBD) 涉及关键的代谢途径,如糖解,酸盐氧化和谷氨酸溶解.
- 线粒体功能障碍在IBD病变发生过程中越来越被认可.
研究的目的:
- 审查当前关于胆固醇T细胞代谢重编程的知识.
- 讨论与IBD相关的结核性T细胞中的线粒体功能障碍.
- 探索针对这些细胞过程的IBD潜在的治疗应用.
主要方法:
- 对T细胞代谢和IBD中线粒体功能的现有文献的综述.
- 分析研究的分析研究糖解,酸盐氧化和谷氨酸溶解在colitogenic T细胞.
- 在IBD模型中检查线粒体功能障碍标记物的证据 (例如mROS,呼吸,生物发生).
主要成果:
- 胆固醇T细胞经历新陈代谢重编程,增强糖解,酸盐氧化和谷氨酸溶解.
- 这些代谢转变有助于增加炎症性细胞因子的产生和IBD中的组织损伤.
- 结核性T细胞表现出线粒体呼吸功能受损,线粒体活性氧物种 (mROS) 升高,平衡改变,线粒体生物发生缺陷.
结论:
- 代谢重编程和线粒体功能障碍在结核性T细胞和IBD病变发生过程中至关重要.
- 针对这些线粒体和代谢途径,为IBD提供了有前途的治疗途径.
- 来自动物模型的证据支持这些策略在IBD治疗中的潜力.
相关概念视频
Inflammatory Bowel Disease II: Crohn's Disease
266
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
266
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
154
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
154
Chronic Bowel Disorders: Introduction
464
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
464
Inflammatory Bowel Disease I: Ulcerative Colitis
199
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
199
T Cell Types and Functions
1.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.0K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
178
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
178


